Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study

J. Ricar, P. Cetkovska, M. Hordinsky, R. Ricarova

. 2022 ; 35 (6) : e15438. [pub] 20220318

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22018137

Grant support
CZ.02.1.01/0.0/0.0/16_019/0000787 Ministry of Education Youth and Sports of the Czech Republic

Bimatoprost is a synthetic prostaglandin structural analogue used among other indications to increase eyelash growth. The aim of this prospective, open-label study was to evaluate the safety and efficacy of topical bimatoprost in the treatment of eyelash loss in alopecia areata totalis (AT) and universalis (AU). Study subjects applied ophthalmic bimatoprost (0.3 mg/ml) solution to the eyelid margins once nightly for at least 12 weeks (mean treatment period was 30.6 weeks). A total of 16 out of 17 subjects completed the study. Only the subjects with eyelashes present at baseline experienced an increase in eyelash length and thickness. No new eyelash regrowth was induced. In patients with AT and AU topical bimatoprost affected existing eyelashes, but failed to induce regrowth of new eyelashes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018137
003      
CZ-PrNML
005      
20220804134600.0
007      
ta
008      
220720s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/dth.15438 $2 doi
035    __
$a (PubMed)35278027
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ricar, Jan $u Department of Dermatovenereology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $1 https://orcid.org/000000032079236X
245    10
$a Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study / $c J. Ricar, P. Cetkovska, M. Hordinsky, R. Ricarova
520    9_
$a Bimatoprost is a synthetic prostaglandin structural analogue used among other indications to increase eyelash growth. The aim of this prospective, open-label study was to evaluate the safety and efficacy of topical bimatoprost in the treatment of eyelash loss in alopecia areata totalis (AT) and universalis (AU). Study subjects applied ophthalmic bimatoprost (0.3 mg/ml) solution to the eyelid margins once nightly for at least 12 weeks (mean treatment period was 30.6 weeks). A total of 16 out of 17 subjects completed the study. Only the subjects with eyelashes present at baseline experienced an increase in eyelash length and thickness. No new eyelash regrowth was induced. In patients with AT and AU topical bimatoprost affected existing eyelashes, but failed to induce regrowth of new eyelashes.
650    _2
$a alopecie $x diagnóza $x farmakoterapie $7 D000505
650    12
$a alopecia areata $7 D000506
650    _2
$a bimatoprost $x škodlivé účinky $7 D000069580
650    12
$a oční řasy $7 D005140
650    _2
$a lidé $7 D006801
650    _2
$a prospektivní studie $7 D011446
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cetkovska, Petra $u Department of Dermatovenereology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Hordinsky, Maria $u Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA
700    1_
$a Ricarova, Renata $u Department of Ophthalmology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
773    0_
$w MED00005384 $t Dermatologic therapy $x 1529-8019 $g Roč. 35, č. 6 (2022), s. e15438
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35278027 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134554 $b ABA008
999    __
$a ok $b bmc $g 1821963 $s 1169380
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 35 $c 6 $d e15438 $e 20220318 $i 1529-8019 $m Dermatologic therapy $n Dermatol Ther $x MED00005384
GRA    __
$a CZ.02.1.01/0.0/0.0/16_019/0000787 $p Ministry of Education Youth and Sports of the Czech Republic
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Archiving options